몰타 - 영어 - Malta Medicines Authority

jv healthcare limited - buserelin - solution for injection - buserelin 1 milligram(s)/millilitre - endocrine therapy

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - leuprorelin acetate 3.78mg equivalent to 3.6 mg leuprorelin - subcutaneous implant - 3.6 mg - active: leuprorelin acetate 3.78mg equivalent to 3.6 mg leuprorelin excipient: polyglactin - palliative treatment of patients with advanced, hormone-dependent prostate carcinoma

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - leuprorelin acetate 5.25mg equivalent to leuprorelin 5 mg - subcutaneous implant - 5 mg - active: leuprorelin acetate 5.25mg equivalent to leuprorelin 5 mg excipient: poly(lactide) - palliative treatment of patients with advanced, hormone-dependent prostate carcinoma

몰타 - 영어 - Malta Medicines Authority

1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - leuprorelin acetate - implant - leuprorelin acetate 5 mg - endocrine therapy

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

merck healthcare pty ltd - cetrorelix, quantity: 0.25 mg - injection, powder for - excipient ingredients: mannitol - indications: prevention of premature luteinization and ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick up and assisted reproductive techniques. in clinical trials cetrotide was used with human menopausal gonadotrophin (hmg), however limited experience with recombinant fsh suggested similar efficacy.

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited - buserelin - implant - 6.3 milligram

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited - buserelin acetate - pdr+solv for soln for inj - 3.6 milligram

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited - buserelin acetate - implant - 9.9 milligram

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

rowex ltd - leuprorelin acetate - implant - 3 mg, 5 milligram(s) - gonadotropin releasing hormone analogues; leuprorelin

유럽 연합 - 영어 - EMA (European Medicines Agency)

merck europe b.v. - cetrorelix (as acetate) - ovulation; ovulation induction - pituitary and hypothalamic hormones and analogues - prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte-pick-up and assisted-reproductive techniques.in clinical trials, cetrotide was used with human menopausal gonadotropin (hmg), however, limited experience with recombinant follicule-stimulating hormone (fsh) suggested similar efficacy.